These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19789385)

  • 1. Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.
    Shavit JA; Manichaikul A; Lemmerhirt HL; Broman KW; Ginsburg D
    Blood; 2009 Dec; 114(26):5368-74. PubMed ID: 19789385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model.
    Lemmerhirt HL; Broman KW; Shavit JA; Ginsburg D
    J Thromb Haemost; 2007 Feb; 5(2):329-35. PubMed ID: 17155961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene.
    Lemmerhirt HL; Shavit JA; Levy GG; Cole SM; Long JC; Ginsburg D
    Blood; 2006 Nov; 108(9):3061-7. PubMed ID: 16873672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11.
    Mohlke KL; Nichols WC; Westrick RJ; Novak EK; Cooney KA; Swank RT; Ginsburg D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15352-7. PubMed ID: 8986815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.
    Nichols WC; Cooney KA; Mohlke KL; Ballew JD; Yang A; Bruck ME; Reddington M; Novak EK; Swank RT; Ginsburg D
    Blood; 1994 Jun; 83(11):3225-31. PubMed ID: 8193357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection on cis-regulatory variation at B4galnt2 and its influence on von Willebrand factor in house mice.
    Johnsen JM; Teschke M; Pavlidis P; McGee BM; Tautz D; Ginsburg D; Baines JF
    Mol Biol Evol; 2009 Mar; 26(3):567-78. PubMed ID: 19088380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
    Meinkoth JH; Meyers KM
    Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level.
    Mohlke KL; Purkayastha AA; Westrick RJ; Ginsburg D
    Genomics; 1998 Nov; 54(1):19-30. PubMed ID: 9806826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
    Ginsburg D; Konkle BA; Gill JC; Montgomery RR; Bockenstedt PL; Johnson TA; Yang AY
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3723-7. PubMed ID: 2786201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of a murine model of von Willebrand disease by gene transfer.
    Pergolizzi RG; Jin G; Chan D; Pierre L; Bussel J; Ferris B; Leopold PL; Crystal RG
    Blood; 2006 Aug; 108(3):862-9. PubMed ID: 16638935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
    Cumming A; Grundy P; Keeney S; Lester W; Enayat S; Guilliatt A; Bowen D; Pasi J; Keeling D; Hill F; Bolton-Maggs PH; Hay C; Collins P;
    Thromb Haemost; 2006 Nov; 96(5):630-41. PubMed ID: 17080221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.
    O'Brien LA; James PD; Othman M; Berber E; Cameron C; Notley CR; Hegadorn CA; Sutherland JJ; Hough C; Rivard GE; O'Shaunessey D; Lillicrap D;
    Blood; 2003 Jul; 102(2):549-57. PubMed ID: 12649144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe.
    Wu QY; Bahnak BR; Coulombel L; Kerbiriou-Nabias D; Drouet L; Piétu G; Meulien P; Pavirani A; Caen JP; Meyer D
    Blood; 1988 May; 71(5):1341-6. PubMed ID: 3258769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
    Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
    Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of bleeding severity in von Willebrand disease.
    Di Paola J
    Curr Hematol Rep; 2005 Sep; 4(5):345-9. PubMed ID: 16131434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting at the variable expressivity of von Willebrand disease.
    Levy G; Ginsburg D
    Thromb Haemost; 2001 Jul; 86(1):144-8. PubMed ID: 11487001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
    Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
    Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2N von Willebrand disease: Characterization and diagnostic difficulties.
    Casonato A; Galletta E; Sarolo L; Daidone V
    Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.